Eric Ende Net Worth - Insider Trades and Bio as of Jun 4, 2026

AVADEL PHARMACEUTICALS PLCSEC CIK: 0001494386

Estimated Net Worth

$3.72 Million

Last Updated: May 19, 2026 11:38 PM EST

Transaction Summary

Total Transactions51

Buy-Sell Ratio∞

Buy Transactions13

Sell Transactions0

Transaction Volume

Total Volume$1.09M

Net Volume$1.09M

Buy Volume$1.09M

Sell Volume$0.00

Trade Analysis

AVG Trade Size-$55.47K

Largest Trade$438.00K

Most Active MonthAug

Most Active Year2019

Trading Sentiment

OverallBullish

Recent TradeNeutral

Last 90 Days0 Trades

ConvictionNone

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Eric J Ende has an estimated net worth of $3.72 Million. This is based on reported shares across multiple companies, which include GENZYME CORP, Matinas BioPharma Holdings, Inc., AVADEL PHARMACEUTICALS PLC, NeuBase Therapeutics, Inc., and PROGENICS PHARMACEUTICALS INC.

2019 was Eric J Ende's most active year for acquiring shares with 12 total transactions. Eric J Ende's most active month to acquire stocks was the month of July. 2026 was Eric J Ende's most active year for disposing of shares, totalling 9 transactions. Eric J Ende's most active month to dispose stocks was the month of January. 2017 saw Eric J Ende paying a total of $876,000.00 for 562,201 shares, this is the most they've acquired in one year. In 2026 Eric J Ende cashed out on 468,962 shares for a total of $4,618,005.00, their largest year based on trade value.

Holdings & Transactions

AVDLavadel pharmaceuticals plc

Updated: Feb 12, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	468.96K	$21.00	-$4.62M	Feb 12, 2026	—	Disposition	—	Feb 12	View
From 4	0.11	22.00K	—	—	Jul 31, 2025	230.90K	Grant	—	Jul 29	View
From 4	0.17	30.00K	$7.84	$235.22K	Jan 14, 2025	208.90K	Purchase	—	Jan 13	View
From 4	0.13	22.00K	—	—	Aug 01, 2024	189.90K	Grant	—	Jul 30	View
From 4	—	33.00K	—	—	Aug 03, 2023	33.00K	Grant	—	Aug 01	View
From 4	0.08	13.00K	$13.93	$181.10K	May 19, 2023	167.90K	Purchase	—	May 18	View
From 4	0.15	20.00K	$7.80	$156.05K	Nov 23, 2022	154.90K	Purchase	—	Nov 22	View
From 4	—	42.00K	—	—	Aug 05, 2022	42.00K	Grant	—	Aug 03	View
From 4	0.35	35.00K	$2.23	$77.89K	Jun 01, 2022	134.90K	Purchase	—	May 31 - 01	View
From 4	0.18	15.00K	$2.45	$36.75K	May 31, 2022	99.90K	Purchase	—	May 27	View
From 4	—	42.00K	—	—	Aug 05, 2021	42.00K	Grant	—	Aug 03	View
From 4	0.25	17.00K	$5.79	$98.38K	Sep 18, 2020	84.90K	Purchase	—	Sep 17	View
From 4	0.08	5.00K	$7.79	$38.93K	Aug 17, 2020	67.90K	Purchase	—	Aug 13	View
From 4	0.31	15.00K	$7.76	$116.36K	Aug 13, 2020	62.90K	Purchase	—	Aug 12	View
From 4	—	42.00K	—	—	Aug 11, 2020	42.00K	Grant	—	Aug 07	View
From 4	0.26	10.00K	$5.97	$59.70K	Dec 05, 2019	47.90K	Purchase	—	Dec 04	View
From 4	0.36	10.00K	$4.98	$49.76K	Nov 19, 2019	105.96K	Purchase	—	Nov 15	View
From 4	—	60.00K	—	—	Aug 09, 2019	95.96K	Grant	—	Aug 07	View
From 4	—	35.96K	—	—	May 24, 2019	35.96K	Grant	—	Jan 31 - 22	View
From 4	—	27.90K	—	—	Feb 04, 2019	27.90K	Grant	—	Jan 31	View
From 3	—	—	—	—	Jan 03, 2019	—	—	—	—	View

MTNBmatinas biopharma holdings, inc.

Updated: Nov 03, 2023VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	437.24K	—	—	Nov 03, 2023	437.24K	Grant	—	Nov 01	View
From 4	—	142.66K	—	—	Nov 16, 2022	142.66K	Grant	—	Nov 14	View
From 4	—	90.88K	—	—	Nov 02, 2021	90.88K	Grant	—	Nov 01	View
From 4	0.25	28.79K	—	—	Jun 24, 2021	144.09K	Options	—	Jun 19	View
From 4	—	122.61K	—	—	Nov 10, 2020	122.61K	Grant	—	Nov 02	View
From 4	0.03	3.60K	—	—	Jun 24, 2020	115.29K	Acquisition	—	Jun 23	View
From 4	1.00	109.82K	—	—	Nov 05, 2019	219.11K	Acquisition	—	Jun 21 - 01	View
From 4	0.22	20.00K	$0.66	$13.20K	Aug 22, 2019	109.29K	Purchase	—	Aug 20	View
From 4	0.29	20.00K	$0.68	$13.65K	Aug 21, 2019	89.29K	Purchase	—	Aug 19	View
From 4/A	—	12.20K	—	—	Apr 03, 2019	12.20K	Grant	—	Apr 03	View
From 4	0.36	15.02K	—	—	Jan 04, 2019	57.09K	Grant	—	Dec 31	View
From 4	—	256.60K	—	—	Nov 05, 2018	256.60K	Grant	—	Nov 01	View
From 4	0.30	9.71K	—	—	Oct 03, 2018	42.07K	Grant	—	Oct 01	View
From 4	1.75	20.59K	—	—	Jul 11, 2018	32.35K	Grant	—	Jun 29	View
From 4	—	12.00	$1,000.00	$12.00K	Jun 22, 2018	12.00	Purchase	—	Jun 21	View
From 4	—	11.76K	—	—	Apr 02, 2018	11.76K	Grant	—	Mar 30	View
From 4	—	250.00K	—	—	Feb 27, 2018	250.00K	Grant	—	Dec 14	View
From 4/A	—	150.00K	$2.92	$438.00K	Jul 19, 2017	150.00K	Grant	—	Apr 03	View
From 4	—	150.00K	$2.92	$438.00K	Apr 21, 2017	150.00K	Grant	—	Apr 03	View
From 3	—	—	—	—	Apr 21, 2017	—	—	—	—	View

NBSEneubase therapeutics, inc.

Updated: Sep 12, 2022VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	37.60K	—	—	Sep 12, 2022	37.60K	Grant	—	Sep 09	View
From 4	—	165.80K	—	—	Jan 05, 2022	165.80K	Grant	—	Jan 01	View
From 3	—	—	—	—	Jan 05, 2022	—	—	—	—	View

progenics pharmaceuticals inc

Updated: Jun 23, 2020

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	56.39K	—	—	Jun 23, 2020	—	Disposition	—	Jun 19	View
From 4	—	16.39K	—	—	Dec 17, 2019	16.39K	Grant	—	Dec 13	View
From 4	—	40.00K	—	—	Dec 17, 2019	40.00K	Grant	—	Dec 13	View
From 3	—	—	—	—	Sep 27, 2019	—	—	—	—	View

genzyme corp

Updated: Apr 06, 2011

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	9.50K	$62.76	-$542.83K	Apr 06, 2011	—	Options	—	Apr 04	View
From 4	—	9.50K	$51.52	$367.08K	Jun 18, 2010	9.50K	Grant	—	Jun 16	View
From 3	—	—	—	—	Jun 18, 2010	—	—	—	—	View

Benzinga

Benzinga

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Holdings & Transactions